Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

NCT07366801

Conditions
Acute Lymphoblastic Leukemia, High Risk, Acute Lymphoblastic Leukemia, Relapse, Acute Myeloid Leukemia, High Risk, +18 more
Locations
  • National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198 Moscow, Russia
View Trial Details
Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
Locations
  • Local Institution - 0016 Portland, Oregon, United States
  • Ut Southwestern Dallas, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
  • Local Institution - 0004 Madison, Wisconsin, United States
View Trial Details
Recruiting

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

NCT06333262

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • New England Cancer Specialists Scarborough, Maine, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

NCT05512390

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +21 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 247752 Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232 Miami, Florida, United States
  • Allina Health System /ID# 251782 Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center /ID# 246715 Omaha, Nebraska, United States
View all 20 locations
View Trial Details

Related conditions